An Act amending the act of December 14, 1992 (P.L.1116, No.145), known as the Wholesale Prescription Drug Distributors License Act, further providing for definitions and for license application.

Added a specific definition for 'virtual manufacturer' to clarify that it applies to businesses manufacturing or distributing drugs/devices without taking physical possession of them in the state.

Established a new 'conditional license' category for manufacturers or virtual manufacturers whose products have not yet received final approval from the U.S. Food and Drug Administration.

Required applicants for conditional licenses to submit proof of FDA application submission (such as application numbers) and documentation of any contract manufacturing organizations involved.

Updated the standard license application requirements to explicitly address scenarios where applicants are virtual manufacturers lacking traditional drug approval codes on product labels.

Set a one-year expiration limit for conditional licenses unless renewed, and mandated that applicants notify the department within five business days of FDA approval or material changes to their operations.